Chaga Immune study abstract

Effect of Chaga Mushroom as a Natural Immune Modulator on Upper-Respiratory Tract Infections (URTIs) and Psychological Mood State Eevia Health study conducted in collaboration with Dr. Shawn M. Talbott and GLH Nutrition, November 17, 2021 Background Heavy exercise or intense training may increase susceptibility to upper respiratory tract infections (URTI) (Nieman et al., 1990; Peters […]

Read more...

Positive results from human clinical study concluded on Feno-Chaga® Organic

Please read the full abstract of the study here. Eevia Health Plc (” Eevia” or” The Company”) has concluded a human clinical study of the effects of Eevia’s branded ingredient Feno-Chaga® Organic on Upper-Respiratory Tract Infections (URTIs) and Psychological Mood State with positive and promising results. Forty (40) healthy long-distance (marathon) runners participated in a […]

Read more...

Eevia Health Plc received new sales orders for organic pine bark extract

Eevia Health Plc, (”Eevia” or ”The Company”), announces that it has received sales orders from a leading organic supplement brand for supply of the Fenoprolic® 70 Organic (organic pine bark extract). The sales value of this start order is c.65,000 EUR, but the customer has a strong record on new product launches, and it is therefore expected to create repeat sales of this product going forward.    Eevia exhibited at the trade show “Supply Side West” in Las Vegas this week (25-28.10.21). In […]

Read more...

Eevia Health Oyj completed first phase of a planned capacity increase and plant improvement

Eevia Health Plc, (”Eevia” or ”The Company”), has installed new capacities and automation equipment for processing and evaporation of natural plant extract liquids. As of August 1st, the newly installed machines and technologies are working satisfactorily, with improved yield, productivity, and cost efficiency. One investment is related to improved berry processing, included a new loading […]

Read more...



Eevia Health lands sales agreement for berry extracts with a minimum contract value of c. SEK 100 million

Eevia Health Plc, (”Eevia” or ”The Company”), a leading health ingredient manufacturer from Finland, today announces that it has entered a multi-year sales agreement for the US market with a key international customer. The agreement is for the supply of a standardized berry extract. The first three years of the sales agreement provides for a […]

Read more...

Subscription of Shares Started

The subscription of shares started today. Information memorandum and teasers (both in English and in Swedish) are now available and you can find them below. Check more information on our IPO pages! Information memorandum Eevia Health Oyj June 2021Teaser Eevia Health Oyj June (English)Teaser Eevia Health Oyj June (Swedish)

Read more...

Eevia Health listing at Spotlight Stock Market

Press Release 01.06.2021 Finnish functional food company Eevia Health – a leading supplier of bioactive plant extracts from berries, mushrooms and pine trees – to list on Spotlight Stock Market NOT FOR PUBLICATION OR DISTRIBUTION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, […]

Read more...